Richter's syndrome in central nervous system with MYD88L265P and CD79b mutation responded well to ibrutinib containing chemotherapy: a case report and review of the literature

Ann Hematol. 2022 Aug;101(8):1869-1872. doi: 10.1007/s00277-022-04827-6. Epub 2022 Apr 29.

Authors

Wei Wang¹, Yan Zhang¹, Danqing Zhao¹, Wei Zhang², Daobin Zhou¹

Affiliations

¹ Department of Hematology, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100005, China.
² Department of Hematology, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100005, China. [email protected].

PMID: 35484253
DOI: 10.1007/s00277-022-04827-6

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Adenine / analogs & derivatives
CD79 Antigens / genetics
Central Nervous System
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
Lymphoma, Large B-Cell, Diffuse* / genetics
Mutation
Piperidines

Substances

CD79 Antigens
CD79B protein, human
Piperidines
ibrutinib
Adenine